View in EDS HTML Full Text PDF Full Text

Golimumab as the First-, Second-, or at Least Third-Line Biologic Agent in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis: Post Hoc Analysis of a Noninterventional Study in Germany.

Saved in:
Bibliographic Details
Title: Golimumab as the First-, Second-, or at Least Third-Line Biologic Agent in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis: Post Hoc Analysis of a Noninterventional Study in Germany.
Authors: Krüger, Klaus1 (AUTHOR), Burmester, Gerd Rüdiger2 (AUTHOR), Wassenberg, Siegfried3 (AUTHOR), Thomas, Matthias H.4 (AUTHOR) matthias.thomas@msd.de
Source: Rheumatology & Therapy. Jun2020, Vol. 7 Issue 2, p371-382. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 143136553
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Golimumab as the First-, Second-, or at Least Third-Line Biologic Agent in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis: Post Hoc Analysis of a Noninterventional Study in Germany.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Krüger%2C+Klaus%22">Krüger, Klaus</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Burmester%2C+Gerd+Rüdiger%22">Burmester, Gerd Rüdiger</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wassenberg%2C+Siegfried%22">Wassenberg, Siegfried</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Thomas%2C+Matthias+H%2E%22">Thomas, Matthias H.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<i> matthias.thomas@msd.de</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Rheumatology+%26+Therapy%22">Rheumatology & Therapy</searchLink>. Jun2020, Vol. 7 Issue 2, p371-382. 12p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=143136553
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40744-020-00204-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 371
    Titles:
      – TitleFull: Golimumab as the First-, Second-, or at Least Third-Line Biologic Agent in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis: Post Hoc Analysis of a Noninterventional Study in Germany.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Krüger, Klaus
      – PersonEntity:
          Name:
            NameFull: Burmester, Gerd Rüdiger
      – PersonEntity:
          Name:
            NameFull: Wassenberg, Siegfried
      – PersonEntity:
          Name:
            NameFull: Thomas, Matthias H.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: Jun2020
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 21986576
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Rheumatology & Therapy
              Type: main
ResultId 1